Feustel PJ - Search Results

1

Longitudinal outcome of Parkinson's disease patients with psychosis.

Factor SA, Feustel PJ, Friedman JH, Comella CL, Goetz CG, Kurlan R, Parsa M, Pfeiffer R; Parkinson Study Group. Factor SA, et al. Among authors: feustel pj. Neurology. 2003 Jun 10;60(11):1756-61. doi: 10.1212/01.wnl.0000068010.82167.cf. Neurology. 2003. PMID: 12796526 Clinical Trial.

2

Clinical comparison of tardive and idiopathic cervical dystonia.

Molho ES, Feustel PJ, Factor SA. Molho ES, et al. Among authors: feustel pj. Mov Disord. 1998 May;13(3):486-9. doi: 10.1002/mds.870130319. Mov Disord. 1998. PMID: 9613742

3

Long-term comparative experience with tolcapone and entacapone in advanced Parkinson's disease.

Factor SA, Molho ES, Feustel PJ, Brown DL, Evans SM. Factor SA, et al. Among authors: feustel pj. Clin Neuropharmacol. 2001 Sep-Oct;24(5):295-9. doi: 10.1097/00002826-200109000-00007. Clin Neuropharmacol. 2001. PMID: 11586115 Clinical Trial.

4

The effect of quetiapine on psychosis and motor function in parkinsonian patients with and without dementia.

Reddy S, Factor SA, Molho ES, Feustel PJ. Reddy S, et al. Among authors: feustel pj. Mov Disord. 2002 Jul;17(4):676-81. doi: 10.1002/mds.10176. Mov Disord. 2002. PMID: 12210856

5

Efficacy and safety of repeated doses of botulinum toxin type B in type A resistant and responsive cervical dystonia.

Factor SA, Molho ES, Evans S, Feustel PJ. Factor SA, et al. Among authors: feustel pj. Mov Disord. 2005 Sep;20(9):1152-60. doi: 10.1002/mds.20531. Mov Disord. 2005. PMID: 15954134 Clinical Trial.

6

Excessive daytime sleepiness in cervical dystonia.

Trotti LM, Esper CD, Feustel PJ, Bliwise DL, Factor SA. Trotti LM, et al. Among authors: feustel pj. Parkinsonism Relat Disord. 2009 Dec;15(10):784-6. doi: 10.1016/j.parkreldis.2009.04.007. Epub 2009 May 15. Parkinsonism Relat Disord. 2009. PMID: 19447065 Clinical Trial.

7

Outcome of adolescent trauma admitted to an adult surgical intensive care unit versus a pediatric intensive care unit.

Sanchez JL, Lucas J, Feustel PJ. Sanchez JL, et al. Among authors: feustel pj. J Trauma. 2001 Sep;51(3):478-80. doi: 10.1097/00005373-200109000-00009. J Trauma. 2001. PMID: 11535894

8

Behavioral and histological neuroprotection by tamoxifen after reversible focal cerebral ischemia.

Zhang Y, Jin Y, Behr MJ, Feustel PJ, Morrison JP, Kimelberg HK. Zhang Y, et al. Among authors: feustel pj. Exp Neurol. 2005 Nov;196(1):41-6. doi: 10.1016/j.expneurol.2005.07.002. Epub 2005 Jul 28. Exp Neurol. 2005. PMID: 16054626

9

Neuroprotection by tamoxifen in focal cerebral ischemia is not mediated by an agonist action at estrogen receptors but is associated with antioxidant activity.

Zhang Y, Milatovic D, Aschner M, Feustel PJ, Kimelberg HK. Zhang Y, et al. Among authors: feustel pj. Exp Neurol. 2007 Apr;204(2):819-27. doi: 10.1016/j.expneurol.2007.01.015. Epub 2007 Jan 24. Exp Neurol. 2007. PMID: 17321521 Free PMC article.

10

Early Experience With New Generation Deep Brain Stimulation Leads in Parkinson's Disease and Essential Tremor Patients.

Shao MM, Liss A, Park YL, DiMarzio M, Prusik J, Hobson E, Adam O, Durphy J, Sukul V, Danisi F, Feustel P, Slyer J, Truong H, Pilitsis JG. Shao MM, et al. Neuromodulation. 2020 Jun;23(4):537-542. doi: 10.1111/ner.13034. Epub 2019 Aug 21. Neuromodulation. 2020. PMID: 31436001

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

247 results

Search Page

Filters